Search by Drug Name or NDC

    NDC 72785-0011-06 cisatracurium besylate 2 mg/mL Details

    cisatracurium besylate 2 mg/mL

    cisatracurium besylate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is CISATRACURIUM BESYLATE.

    Product Information

    NDC 72785-0011
    Product ID 72785-0011_edbc4b0d-92ea-48b7-a7d7-406c82d40221
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name cisatracurium besylate
    Proprietary Name Suffix n/a
    Non-Proprietary Name cisatracurium besylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name CISATRACURIUM BESYLATE
    Labeler Name Zydus Lifesciences Limited
    Pharmaceutical Class Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213527
    Listing Certified Through 2024-12-31

    Package

    NDC 72785-0011-06 (72785001106)

    NDC Package Code 72785-0011-6
    Billing NDC 72785001106
    Package 10 VIAL in 1 CARTON (72785-0011-6) / 10 mL in 1 VIAL (72785-0011-1)
    Marketing Start Date 2020-11-05
    NDC Exclude Flag N
    Pricing Information N/A
    << 72785-0009-06 72786-0101-01 >>

    Contents

    Standard Product Labeling (SPL)/Prescribing Information SPL ac58faa8-7291-4128-9646-c00be0ce3f81 Details

    Revised: 10/2022
    Document Id: edbc4b0d-92ea-48b7-a7d7-406c82d40221
    Set id: ac58faa8-7291-4128-9646-c00be0ce3f81
    Version: 2
    Effective Time: 20221017